Epistaxol solución cutánea
As listed in the register: Epistaxol solución cutánea
300 mg / 5 mg / 2 mg / 5 mg · solución cutánea
- Available without prescription
- Blood, clotting and anaemia
- Active substance
- Epinefrina + fenazona + nafazolina + rutósido
- Used in
- Blood, clotting and anaemia
- Made by
- Medical S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Medical S.A. |
|---|---|
| Active substance | Epinefrina + fenazona + nafazolina + rutósido |
| Used in | Blood, clotting and anaemia |
| Strength | 300 mg / 5 mg / 2 mg / 5 mg |
| Form | solución cutánea |
| Classification | B02BC30 · Blood, clotting and anaemia |
| Route | uso cutáneo |
| Marketed | No — authorised but not currently marketed, according to the register |
| Nº Registro | 42972 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.